Pathway Modeling of Genomic and Tissue-Specific Transcriptomic Architecture Identifies Personalized Mechanisms of Atrial Fibrillation Risk
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.